Article info
Clinical science
Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis
- Correspondence to Dr Antoine Rousseau, Ophthalmology, Bicêtre Hospital, Assistance Publique–Hôpitaux de Paris, Paris-Sud University, French Reference Center for Familial Amyloid Polyneuropathies (NNERF), Le Kremlin-Bicêtre 94275, France; antoine.rousseau{at}aphp.fr
Citation
Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis
Publication history
- Received October 12, 2019
- Revised December 10, 2019
- Accepted December 26, 2019
- First published January 16, 2020.
Online issue publication
September 21, 2020
Article Versions
- Previous version (16 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.